(The H4-Index of Platelets is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Immunothrombosis and thromboinflammation in host defense and disease92
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients51
Platelet Rich Plasma in Orthopedic Surgical Medicine.49
Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine39
PRP in wound healing applications38
Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity35
Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition34
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors33
Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases32
The thrombopoietin receptor: revisiting the master regulator of platelet production31
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients30
Role of platelets and megakaryocytes in adaptive immunity30
In vivo evaluation of the biocompatibility and biodegradation of a new denatured plasma membrane combined with liquid PRF (Alb-PRF)30
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty29
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure27
Rotational thromboelastometry (ROTEM) profiling of COVID–19 patients25
Neonatal platelet physiology and implications for transfusion24
Platelet-rich plasma promotes bone formation, restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head24
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension23
Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous 22
Isolation of murine bone marrow by centrifugation or flushing for the analysis of hematopoietic cells – a comparative study21
Platelet removal by single-step centrifugation21
Platelets and viruses21